Status: Recruiting
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
The purpose of this study is to evaluate the efficacy and safety of KIg 10 (Intravenous Immunoglobulin 10%) in adult patients with chronic primary ITP
Participants needed: 40
Trial details
Phase: Phase 3Age: 18-70Biological sex: AllType: InterventionalSponsor: Kedrion S.p.A.Updated: Jun 16, 2026Locations: 27
Eligibility criteria
Male or female, 18-70 years of age. [+7]
Patients incapable of giving informed consent. [+34]